• DNase I (RNase-free): A Workflow Decision Guide

  2026-08-12

  DNase I (RNase-free) is more than a DNA cleanup reagent: its ion-dependent cleavage chemistry can determine whether RNA, chromatin, or protein assays remain interpretable. This guide connects mechanism, matrix effects, and workflow design to practical nucleic acid decisions.

• BML-277: Precision Chk2 Inhibitor Workflows

  2026-08-11

  BML-277 combines nanomolar biochemical potency with a practical cellular concentration range for dissecting checkpoint signaling, T-cell survival, and DNA damage pathways. This workflow-oriented guide shows how to connect ATP-competitive Chk2 inhibition with the nuclear cGAS–TRIM41–ORF2p axis while separating validated findings from testable research hypotheses.

• SARS-CoV-2 Variant Shifts in ACE2 Usage

  2026-08-11

  Shukla et al. developed a barcoded pseudotyped-virus assay that simultaneously measures how multiple ACE2 sequences support entry by SARS-CoV-2 spike variants. The study shows that variant effects are modest for human ACE2 but substantially reshape compatibility with animal ACE2 orthologs, providing a scalable framework for studying receptor usage and potential host-range changes.

• Reactive Oxygen Species Assay Kit: DHE Workflow

  2026-08-10

  Build a live-cell superoxide workflow for toxin, immunotoxicity, and apoptosis research with practical controls and optimization steps. This guide shows how to use DHE signal alongside caspase-1 and inflammatory readouts without confusing superoxide measurement with total ROS detection.

• 740 Y-P: PI 3-Kinase Activator Workflows

  2026-08-09

  740 Y-P is a cell-permeable PI 3-kinase activator for connecting PI3K/AKT signaling to measurable changes in vesicular trafficking, survival, and inflammatory cell stress. This guide translates product specifications and a mitophagy-focused chondrocyte study into practical assay designs, controls, and troubleshooting steps.

• Nuclear cGAS–TRIM41 Restricts L1 Retrotransposition

  2026-08-08

  This study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of the essential L1 protein ORF2p. The findings connect DNA damage signaling with posttranslational control of mobile genetic elements, offering a mechanistic framework for genome integrity research in aging and cancer.

• BCECF for Extracellular pH and Efferocytosis

  2026-08-07

  BCECF converts extracellular acidification into a quantitative ratiometric signal for ion transport, metabolism, and inflammatory microenvironment studies. Its membrane-impermeant design complements efferocytosis models by separating extracellular pH changes from intracellular dye redistribution.

• Hydroxytyrosol: Advanced Protocols for Oxidative Stress Rese

  2026-08-07

  Hydroxytyrosol, a potent 4-(2-hydroxyethyl)benzene-1,2-diol, stands apart for its high solubility and verified bioactivity, enabling robust oxidative stress and inflammation studies. This article translates reference-driven mechanistic insights into actionable protocols, troubleshooting tips, and advanced applications for cardiovascular and kidney disease research.

• JZL184: Selective Monoacylglycerol Lipase Inhibitor for Endo

  2026-08-06

  JZL184 is a potent monoacylglycerol lipase inhibitor used to modulate endocannabinoid signaling. By elevating brain 2-AG levels, it enables precise investigation of CB1 receptor-mediated effects in pain and anxiety models. The compound is benchmarked for high selectivity, purity, and reproducibility in neuropharmacology workflows.

• CHI3L1-IN-5: Redefining NF-κB Pathway Inhibition in Neuroinf

  2026-08-06

  CHI3L1-IN-5 (Compound Z17) delivers a dual-mechanism approach to neuroinflammation research, combining selective CHI3L1 inhibition with restoration of astrocyte function. This article provides mechanistic insights, experimental protocol parameters, and translational guidance, positioning Z17 as a next-generation tool for dissecting and potentially modulating NF-κB-driven neurodegenerative processes. Drawing on recent evidence and competitive context, it offers a strategic roadmap for researchers targeting Alzheimer’s disease and related disorders.

• Salinomycin in HCC: Mechanistic Insights & Translational Str

  2026-08-05

  Explore how Salinomycin, a polyether ionophore antibiotic, is reshaping hepatocellular carcinoma research by uniquely integrating mechanistic clarity with strategic workflow design. This article goes beyond standard product summaries, offering translational researchers actionable insights for protocol optimization, risk management, and future outlook, grounded in recent evidence and comparative analysis.

• Palbociclib (PD0332991) in Cancer Cell Cycle Arrest Workflow

  2026-08-05

  Palbociclib (PD0332991) Isethionate empowers researchers to dissect CDK4/6-driven cell cycle regulation and apoptosis in cancer models, offering robust tools for breast and colorectal cancer research. This guide delivers actionable protocol enhancements, troubleshooting insights, and translates cutting-edge findings on cancer stemness and chemoresistance into practical assay choices.

• Bismuth Subsalicylate: Precision Tools for Membrane Biology

  2026-08-04

  Explore the advanced utility of Bismuth Subsalicylate in membrane biology and apoptosis detection research. This in-depth analysis reveals how 1,3,2λ2-benzodioxabismin-4-one enables next-generation experimental control and data fidelity.

• Ertugliflozin (PF-04971729): Selective SGLT2 Inhibition for

  2026-08-04

  Ertugliflozin (PF-04971729) is a highly selective inhibitor of sodium-glucose co-transporter 2, enabling precise interrogation of renal glucose reabsorption pathways in diabetes mellitus research. Clinical and preclinical evidence supports its efficacy in glycemic control, weight reduction, and cardiovascular risk mitigation, with a safety profile comparable to other SGLT2 inhibitors.

• SB 431542: ALK5 Inhibitor Protocols for Stem Cell and Tumor

  2026-08-03

  SB 431542 stands out as a benchmark ALK5 inhibitor, offering high selectivity and robust performance in both stem cell differentiation and anti-tumor immunology workflows. This guide translates recent organoid and oncology research into actionable protocols, troubleshooting tips, and comparative advantages for scientists leveraging TGF-β pathway inhibition.

8070 records 3/538 page Previous Next 12345 下5页 Last page